“Half-Life-Extended Monoclonal Antibody APG777 for Atopic Dermatitis: Design of the Phase 2 APEX Study”. 2025. SKIN The Journal of Cutaneous Medicine 9 (2): s550. https://doi.org/10.25251/skin.10.supp.550.